PUBLISHER: Persistence Market Research | PRODUCT CODE: 1457354

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1457354

Neurointerventional Device Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

PUBLISHED: January 25, 2024

PAGES: 209 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Persistence Market Research presents a comprehensive analysis of the global neurointerventional device market, offering valuable insights into the industry's dynamics, growth drivers, challenges, and emerging trends. This report delivers an exclusive overview of the market's structure, backed by data and statistics that project the market's trajectory from 2023 to 2030.

The global neurointerventional device market is forecast to expand at a CAGR of 4.7% and thereby increase from a value of US$26 Bn in 2023, to US$ 35.8 Bn by the end of 2030.

Key Insights:

Neurointerventional Device Market Size (2023E): US$26 Bn
Projected Market Value (2030F): US$35.8 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 4.7%
Historical Market Growth Rate (CAGR 2018 to 2022): 4.3%

Neurointerventional Device Market - Report Scope:

The neurointerventional device market encompasses a wide array of medical devices and equipment used in minimally invasive procedures to diagnose and treat various neurological conditions. These devices include stents, embolization coils, catheters, and flow diverters, among others. The market's growth is driven by factors such as technological advancements, increasing prevalence of neurological disorders, and growing demand for minimally invasive surgical procedures. Moreover, the rising geriatric population and the subsequent surge in age-related neurological ailments further propel market expansion.

Market Growth Drivers:

The global neurointerventional device market is primarily fueled by the escalating prevalence of neurological disorders such as stroke, aneurysms, and cerebral vascular malformations. Technological advancements in neurointerventional devices, including the development of bioresorbable stents and advanced imaging techniques, have significantly improved patient outcomes and reduced procedural risks. Additionally, the growing adoption of minimally invasive neurointerventional procedures, characterized by shorter hospital stays and quicker recovery times, augments market growth.

Market Restraints:

Despite promising growth prospects, the neurointerventional device market faces challenges such as stringent regulatory requirements, high procedural costs, and limited reimbursement policies. Moreover, concerns regarding the long-term efficacy and safety of certain neurointerventional devices, along with the risks associated with device-related complications, pose significant barriers to market expansion. Addressing these challenges requires sustained investments in research and development, along with stringent quality control measures to ensure product safety and efficacy.

Market Opportunities:

The neurointerventional device market presents lucrative opportunities driven by ongoing technological innovations and a growing focus on personalized medicine. Advancements in imaging technologies such as MRI and CT angiography facilitate precise diagnosis and treatment planning, thereby expanding the scope of neurointerventional procedures. Furthermore, increasing investments in healthcare infrastructure, particularly in emerging economies, create favorable market conditions for the adoption of neurointerventional devices. Collaborative efforts between industry players and healthcare providers to develop innovative treatment solutions tailored to specific neurological conditions further unlock growth opportunities in the market.

Key Questions Answered in the Report:

What are the key factors driving the growth of the neurointerventional device market?
Which neurological conditions represent the most significant opportunities for market expansion?
How are technological advancements reshaping the competitive landscape of the neurointerventional device market?
Who are the leading players in the neurointerventional device market, and what strategies are they employing to maintain their market positions?
What are the emerging trends and future prospects in the global neurointerventional device market?

Competitive Intelligence and Business Strategy:

Key players in the global neurointerventional device market, including Abbott Laboratories, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd. (Roche Diagnostics), Hologic, Inc., Laboratory Corporation of America Holdings, PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific, Inc., focus on innovation and strategic collaborations to enhance their market presence. These companies invest heavily in research and development to introduce novel neurointerventional devices that address unmet clinical needs and offer improved patient outcomes. Collaborations with healthcare institutions and academic research centers facilitate the development of cutting-edge technologies and foster clinical evidence generation. Moreover, emphasis on physician training programs and patient education initiatives enhances market penetration and sustains long-term growth in the competitive neurointerventional device market.

Key Companies Profiled:

Abbott Laboratories
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
Danaher Corporation (Cepheid)
F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
Hologic, Inc.
Laboratory Corporation of America Holdings
PerkinElmer, Inc.
Quest Diagnostics
Thermo Fisher Scientific, Inc.

Neurointerventional Device Market Research Segmentation:

By Product:

Embolic Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Embolic Protection Device
Flow Diverters Device
Intrasaccular Device
Liquid Embolic
Balloons
Stent Retrievers

By Technique:

Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption

By End User:

Hospitals
Ambulatory Surgical Centers

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33941

1. Executive Summary

1.1. Global Neurointerventional Device Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Neurointerventional Device Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Neurointerventional Device Market Outlook: Product
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  - 3.3.3.1. Embolic Coils
  - 3.3.3.2. Carotid Stents
  - 3.3.3.3. Intracranial Stents
  - 3.3.3.4. Neurovascular Thrombectomy
  - 3.3.3.5. Embolic Protection Device
  - 3.3.3.6. Flow Diverters Device
  - 3.3.3.7. Intrasaccular Device
  - 3.3.3.8. Liquid Embolic
  - 3.3.3.9. Balloons
  - 3.3.3.10. Stent Retrievers
3.4. Market Attractiveness Analysis: Product
3.5. Global Neurointerventional Device Market Outlook: Technique
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  - 3.5.3.1. Neurothrombectomy Procedure
  - 3.5.3.2. Cerebral Angiography
  - 3.5.3.3. Stenting
  - 3.5.3.4. Coiling Procedures
  - 3.5.3.5. Flow Disruption
3.6. Market Attractiveness Analysis: Technique
3.7. Global Neurointerventional Device Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. Ambulatory Surgical Centers
3.8. Market Attractiveness Analysis: End User

4. Global Neurointerventional Device Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product
- 5.3.3. By Technique
- 5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 5.5.1. Embolic Coils
- 5.5.2. Carotid Stents
- 5.5.3. Intracranial Stents
- 5.5.4. Neurovascular Thrombectomy
- 5.5.5. Embolic Protection Device
- 5.5.6. Flow Diverters Device
- 5.5.7. Intrasaccular Device
- 5.5.8. Liquid Embolic
- 5.5.9. Balloons
- 5.5.10. Stent Retrievers s
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 5.6.1. Neurothrombectomy Procedure
- 5.6.2. Cerebral Angiography
- 5.6.3. Stenting
- 5.6.4. Coiling Procedures
- 5.6.5. Flow Disruption
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Hospitals
- 5.7.2. Ambulatory Surgical Centers
5.8. Market Attractiveness Analysis

6. Europe Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By Technique
- 6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 6.5.1. Embolic Coils
- 6.5.2. Carotid Stents
- 6.5.3. Intracranial Stents
- 6.5.4. Neurovascular Thrombectomy
- 6.5.5. Embolic Protection Device
- 6.5.6. Flow Diverters Device
- 6.5.7. Intrasaccular Device
- 6.5.8. Liquid Embolic
- 6.5.9. Balloons
- 6.5.10. Stent Retrievers
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 6.6.1. Neurothrombectomy Procedure
- 6.6.2. Cerebral Angiography
- 6.6.3. Stenting
- 6.6.4. Coiling Procedures
- 6.6.5. Flow Disruption
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Hospitals
- 6.7.2. Ambulatory Surgical Centers
6.8. Market Attractiveness Analysis

7. East Asia Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Technique
- 7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 7.5.1. Embolic Coils
- 7.5.2. Carotid Stents
- 7.5.3. Intracranial Stents
- 7.5.4. Neurovascular Thrombectomy
- 7.5.5. Embolic Protection Device
- 7.5.6. Flow Diverters Device
- 7.5.7. Intrasaccular Device
- 7.5.8. Liquid Embolic
- 7.5.9. Balloons
- 7.5.10. Stent Retrievers
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 7.6.1. Neurothrombectomy Procedure
- 7.6.2. Cerebral Angiography
- 7.6.3. Stenting
- 7.6.4. Coiling Procedures
- 7.6.5. Flow Disruption
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Hospitals
- 7.7.2. Ambulatory Surgical Centers
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Technique
- 8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 8.5.1. Embolic Coils
- 8.5.2. Carotid Stents
- 8.5.3. Intracranial Stents
- 8.5.4. Neurovascular Thrombectomy
- 8.5.5. Embolic Protection Device
- 8.5.6. Flow Diverters Device
- 8.5.7. Intrasaccular Device
- 8.5.8. Liquid Embolic
- 8.5.9. Balloons
- 8.5.10. Stent Retrievers
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 8.6.1. Neurothrombectomy Procedure
- 8.6.2. Cerebral Angiography
- 8.6.3. Stenting
- 8.6.4. Coiling Procedures
- 8.6.5. Flow Disruption
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Hospitals
- 8.7.2. Ambulatory Surgical Centers
8.8. Market Attractiveness Analysis

9. Latin America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Technique
- 9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 9.5.1. Embolic Coils
- 9.5.2. Carotid Stents
- 9.5.3. Intracranial Stents
- 9.5.4. Neurovascular Thrombectomy
- 9.5.5. Embolic Protection Device
- 9.5.6. Flow Diverters Device
- 9.5.7. Intrasaccular Device
- 9.5.8. Liquid Embolic
- 9.5.9. Balloons
- 9.5.10. Stent Retrievers
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 9.6.1. Neurothrombectomy Procedure
- 9.6.2. Cerebral Angiography
- 9.6.3. Stenting
- 9.6.4. Coiling Procedures
- 9.6.5. Flow Disruption
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Hospitals
- 9.7.2. Ambulatory Surgical Centers
9.8. Market Attractiveness Analysis

10. Middle East & Africa Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Technique
- 10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 10.5.1. Embolic Coils
- 10.5.2. Carotid Stents
- 10.5.3. Intracranial Stents
- 10.5.4. Neurovascular Thrombectomy
- 10.5.5. Embolic Protection Device
- 10.5.6. Flow Diverters Device
- 10.5.7. Intrasaccular Device
- 10.5.8. Liquid Embolic
- 10.5.9. Balloons
- 10.5.10. Stent Retrievers
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
- 10.6.1. Neurothrombectomy Procedure
- 10.6.2. Cerebral Angiography
- 10.6.3. Stenting
- 10.6.4. Coiling Procedures
- 10.6.5. Flow Disruption
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Hospitals
- 10.7.2. Ambulatory Surgical Centers
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Abbott Laboratories
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Becton, Dickinson and Company (BD)
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Bio-Rad Laboratories, Inc.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Danaher Corporation (Cepheid)
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Hologic, Inc.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Laboratory Corporation of America Holdings
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. PerkinElmer, Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Quest Diagnostics
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Thermo Fisher Scientific, Inc.
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ